ロード中...
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials
Simulation studies have shown that novel designs such as the continual reassessment method and the Bayesian optimal interval (BOIN) design outperform the 3 + 3 design by recommending the maximum tolerated dose (MTD) more often, using less patients, and allotting more patients to the MTD. However, it...
保存先:
| 出版年: | JCO Precis Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Health
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8232832/ https://ncbi.nlm.nih.gov/pubmed/34250415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.21.00136 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|